Fatalities from blood transfusion

Area of Science:

• Transfusion Medicine
• Patient Safety
• Hepatitis Research

Background:

• Blood transfusions are critical medical procedures.
• Adverse events associated with blood transfusions require ongoing monitoring.
• The Food and Drug Administration (FDA) collects data on transfusion-related fatalities.

Purpose of the Study:

• To analyze fatalities reported to the FDA following blood transfusions between 1976 and 1979.
• To categorize the causes of transfusion-related deaths.
• To identify areas for improvement in transfusion safety.

Main Methods:

• Retrospective analysis of fatality reports submitted to the FDA.
• Categorization of reported deaths based on identified causes.
• Review of data from April 3, 1976, to December 31, 1979.

Main Results:

• A total of 113 fatalities were reported.
• 33 deaths were attributed to posttransfusion hepatitis.
• 47 deaths (61%) resulted from "clerical errors" (e.g., wrong blood type administered).
• 8 deaths were due to laboratory errors.
• 22 deaths were attributed to miscellaneous, often unpreventable, causes.

Conclusions:

• Clerical errors represent a significant and preventable cause of transfusion-related mortality.
• Posttransfusion hepatitis remains a concern, though potentially less frequent than errors.
• Continuous vigilance and error reduction strategies are crucial for enhancing blood transfusion safety.